Medicare Enrolled

Dr. Sameera Daud-Ahmad, MD

Endocrinology · Edgewater, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
725 RIVER RD STE 106, Edgewater, NJ 07020
2017815850
In practice since 2007 (18 years)
NPI: 1073700381 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Daud-Ahmad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Daud-Ahmad? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Daud-Ahmad

Dr. Sameera Daud-Ahmad is an endocrinology specialist in Edgewater, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Daud-Ahmad performed 2,953 Medicare services across 664 unique beneficiaries.

Between the years covered by Open Payments, Dr. Daud-Ahmad received a total of $10,153 from 47 pharmaceutical and/or device companies across 407 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Daud-Ahmad is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 20% volume in NJ $10,153 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,953
Medicare services
Top 20% in NJ for endocrinology
664
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~164 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,260 $19 $52
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
622 $100 $250
Remote patient monitoring management, 20 min/month
Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month.
244 $43 $101
Remote patient monitoring device, 30 days
Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period.
242 $46 $120
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
226 $28 $100
Hemoglobin a1c level, by device for home use 104 $10 $20
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
60 $140 $270
Continuous glucose monitoring, sensor under skin
This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment.
54 $131 $300
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
46 $125 $263
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
23 $92 $200
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
21 $67 $150
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
19 $63 $150
Vaccine administration
The process of giving a vaccine to a patient. This code covers the administration service only and does not include the cost of the vaccine itself.
16 $18 $50
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
16 $76 $100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,153
Total received (2018-2024)
Avg $1,450/year across 7 years
Top 16% in NJ for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
407
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,152 (60.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,237 (22.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,764 (17.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,900
2023
$1,404
2022
$1,593
2021
$3,246
2020
$667
2019
$277
2018
$65

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Corcept Therapeutics
$1,752
Lilly USA, LLC
$232
Novo Nordisk Inc
$154
Boehringer Ingelheim Pharmaceuticals, Inc.
$81
SANOFI-AVENTIS U.S. LLC
$80
Medtronic, Inc.
$69
Amgen Inc.
$62
Insulet Corporation
$56
Chiesi USA, Inc.
$54
Acella Pharmaceuticals, LLC
$46
RECORDATI_RARE_DISEASES_INC.
$46
ABBVIE INC.
$42
Abbott Laboratories
$35
Amneal Pharmaceuticals LLC
$34
Dexcom, Inc.
$29
Astellas Pharma US Inc
$21
Lexicon Pharmaceuticals, Inc.
$17
Mannkind Corporation
$16
Amphastar Pharmaceuticals, Inc.
$16
Echosens North America, Inc.
$15
Alexion Pharmaceuticals, Inc.
$15
Rhythm Pharmaceuticals, Inc.
$15
Xeris Pharmaceuticals, Inc.
$14
Top 3 companies account for 73.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$3,118
Corcept Therapeutics
$1,772
Lilly USA, LLC
$849
SANOFI-AVENTIS U.S. LLC
$432
Amneal Pharmaceuticals LLC
$366
Amgen Inc.
$351
Medtronic, Inc.
$289
AbbVie Inc.
$266
Boehringer Ingelheim Pharmaceuticals, Inc.
$264
Merck Sharp & Dohme Corporation
$258
AstraZeneca Pharmaceuticals LP
$245
Dexcom, Inc.
$243
PFIZER INC.
$200
Xeris Pharmaceuticals, Inc.
$172
Insulet Corporation
$137
Mannkind Corporation
$114
Allergan, Inc.
$111
CeQur Corporation
$80
ABBVIE INC.
$72
Merck Sharp & Dohme LLC
$68
Zealand Pharma US, Inc.
$64
Abbott Laboratories
$62
Chiesi USA, Inc.
$54
Amarin Pharma Inc.
$54
Acella Pharmaceuticals, LLC
$46
RECORDATI_RARE_DISEASES_INC.
$46
Alexion Pharmaceuticals, Inc.
$43
Bayer HealthCare Pharmaceuticals Inc.
$42
Currax Pharmaceuticals LLC
$33
Intuity Medical Inc
$29
DEXCOM, INC.
$26
Astellas Pharma US Inc
$21
VIVUS LLC
$19
Ascendis Pharma Inc
$17
Lexicon Pharmaceuticals, Inc.
$17
Amryt Pharma Holdings Ltd
$17
IBSA Pharma Inc.
$17
Tandem Diabetes Care, Inc.
$16
Amphastar Pharmaceuticals, Inc.
$16
Echosens North America, Inc.
$15
Rhythm Pharmaceuticals, Inc.
$15
Acerus Pharmaceuticals Corporation
$14
Horizon Therapeutics plc
$14
Ortho Dermatologics, a division of Bausch Health US, LLC
$13
VistaPharm, Inc.
$12
Eisai Inc.
$12
Becton, Dickinson and Company
$11
Top 3 companies account for 56.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Aimovig · BD Nano · BELSOMRA · Belviq · CONTRAVE · CeQur Simplicity · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · Enbrel · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FibroScan · GVOKE HYPOPEN · GVOKE PFS · IMCIVREE · INPEN SMART INSULIN DELIVERY SYSTEM · InPen · JANUVIA · JARDIANCE · JUBLIA · Kerendia · Korlym · LICART · MINIMED 670G · MINIMED 780G · MOUNJARO · MYCAPSSA · NP Thyroid 60 · Natesto · Omnipod · Ozempic · PANCREAZE · Pogo Automatic Blood Glucose Monitoring System · RECORLEV · RYBELSUS · Rybelsus · SIGNIFOR LAR · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tresiba · UBRELVY · UNITHROID · VRAYLAR · Vascepa · Veozah · Wegovy · ZEGALOGUE · ZEPBOUND · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (61%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Edgewater?
Compare endocrinologists in the Edgewater area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
682
Per 100K population
71.4
County median income
$123,715
Nearest hospital
NEW YORK STATE PSYCHIATRIC INSTITUTE
1.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Daud-Ahmad is a clinical cardiology specialist, with above-average Medicare volume (top 20% in NJ), with low-engagement industry engagement in the top 16% of NJ peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Daud-Ahmad experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Daud-Ahmad performed 1,260 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Daud-Ahmad receive payments from pharmaceutical companies?
Yes. Dr. Daud-Ahmad received a total of $10,153 from 47 companies across 407 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Daud-Ahmad's costs compare to other endocrinologists in Edgewater?
Dr. Daud-Ahmad's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Daud-Ahmad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →